Transversalis Fascia Plane Block for Iliac Bone Graft in Children

April 9, 2026 updated by: Jin-Tae Kim, Seoul National University Hospital

Comparison Between Ultrasound-guided Transversus Abdominis Plane and Transversalis Fascia Plane Block for Pediatric Patients Undergoing Alveoloplasty With Iliac Bone Graft: a Prospective Randomized Controlled Trial

The purpose of this study is to determine which method is more effective in postoperative pain control in children undergoing iliac bone grafting for alveoloplasty under general anesthesia: ultrasound-guided transverse abdominal blockade or transversalis fascia plane block

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, South Korea, 110-744
        • Seoul National University Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 7 years and older but under 18 undergoing iliac bone grafting for alveoloplasty

Exclusion Criteria:

  • Patients with diseases that affect pain sensitivity differently from the general population (e.g., congenital insensitivity to pain with anhidrosis, complex regional pain syndrome, etc.)
  • Cases where there is difficulty in expressing pain (due to cognitive or functional deficits, or limited ability to communicate)
  • Unstable vital signs (heart rate, blood pressure)
  • Common contraindications for Ropivacaine: 1) Patients with a history of hypersensitivity to this drug or other amide local anesthetics, 2) Patients in a state of major bleeding or shock, 3) Patients with inflammation at or around the site of administration, 4) Patients with sepsis, 5) Intravenous regional anesthesia (Bier block)
  • History of allergy to opioid medications
  • Severe renal impairment (Creatinine >3.0mg/dL)
  • Severe liver function abnormalities (aspartate transaminase > 120 unit/L, alanine aminotransferase > 120 unit/L)
  • Peripheral nervous system disorders
  • Other cases deemed unsuitable by the researcher

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: transversalis fascial plane block
ultrasound guidance transversalis fascial plane block after iliac bone graft
Active Comparator: transversus abdominis plane block
ultrasound guidance posterior transversus abdominis plane block after iliac bone graft

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total consumption of opioid (mcg/kg)
Time Frame: from the end of surgery up to 24 hours later
total opioid consumption at 24 hours after the end of surgery
from the end of surgery up to 24 hours later

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain score
Time Frame: at 30 minutes, 1 hour, 3 hours, 6 hours, 24 hours after the end of surgery
Pain scores is assessed by Numerical Rating Scale, which requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable
at 30 minutes, 1 hour, 3 hours, 6 hours, 24 hours after the end of surgery
Total consumption of non-opioid (mg/kg)
Time Frame: within 24 hours after the end of surgery
Non-opioid analgesics usage per body weight within 24 hours after surgery
within 24 hours after the end of surgery
The incidence of side effects of analgesic medications (percent)
Time Frame: within 24 hours after the end of surgery
Analgesic-related side effects (nausea, vomiting, constipation, pruritis, dizziness, dry mouth, somnolence, etc.) within 24 hours after surgery.
within 24 hours after the end of surgery
Cold sensation
Time Frame: at 30 minutes after the end of surgery
Evaluation of the distribution of lost cold sensation in the skin in the recovery room (Dermatomal distribution of the loss of cold sensation using an alcohol swab at post-anesthesia care unit, assessed by a blinded assessor in the Post Anesthesia Care Unit).
at 30 minutes after the end of surgery
Satisfaction score
Time Frame: at 24 hours after the end of surgery
Patient satisfaction score (0-10 points, with 10 being very satisfied and 0 being very dissatisfied).
at 24 hours after the end of surgery
Sleep quality score
Time Frame: at 24 hours after the end of surgery
Quality of sleep on the day of operation (satisfaction score, 0-10 points, with 10 being very satisfied and 0 being very dissatisfied).
at 24 hours after the end of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2024

Primary Completion (Actual)

December 30, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

May 3, 2024

First Submitted That Met QC Criteria

May 3, 2024

First Posted (Actual)

May 7, 2024

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain, Acute

Clinical Trials on transversalis fascial plane block

Subscribe